Optic Neuritis Completed Phase 3 Trials for Glatiramer (DB05259)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

DBCOND0027863 (Optic Neuritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00856635A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)Treatment